These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 8178699

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Daily cocaine use patterns: effects of contextual and psychological variables.
    Palij M, Rosenblum A, Magura S, Handelsman L, Stimmel B.
    J Addict Dis; 1996; 15(4):13-37. PubMed ID: 8943580
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. 1990-1991 survey of pharmacotherapies used in the treatment of cocaine abuse.
    Halikas JA, Nugent SM, Crosby RD, Carlson GA.
    J Addict Dis; 1993; 12(2):129-39. PubMed ID: 8476938
    [Abstract] [Full Text] [Related]

  • 45. A pilot trial of amantadine for ambulatory withdrawal for cocaine dependence.
    Morgan C, Kosten T, Gawin F, Kleber H.
    NIDA Res Monogr; 1988; 81():81-5. PubMed ID: 3136395
    [No Abstract] [Full Text] [Related]

  • 46. Tryptophan depletion and attenuation of cue-induced craving for cocaine.
    Satel SL, Krystal JH, Delgado PL, Kosten TR, Charney DS.
    Am J Psychiatry; 1995 May; 152(5):778-83. PubMed ID: 7726319
    [Abstract] [Full Text] [Related]

  • 47. Medications development at the National Institute on Drug Abuse: focus on cocaine.
    Johnson DN, Vocci FJ.
    NIDA Res Monogr; 1993 May; 135():57-70. PubMed ID: 8289904
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Absence of acute cocaine interactions with the MAO-B inhibitor selegiline.
    Haberny KA, Walsh SL, Ginn DH, Wilkins JN, Garner JE, Setoda D, Bigelow GE.
    Drug Alcohol Depend; 1995 Jul; 39(1):55-62. PubMed ID: 7587975
    [Abstract] [Full Text] [Related]

  • 50. Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels.
    Gorelick DA, Wilkins JN.
    Drug Alcohol Depend; 2006 Feb 01; 81(2):189-95. PubMed ID: 16051446
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Acute interactions of buprenorphine with intravenous cocaine and morphine: an investigational new drug phase I safety evaluation.
    Teoh SK, Mendelson JH, Mello NK, Kuehnle J, Sintavanarong P, Rhoades EM.
    J Clin Psychopharmacol; 1993 Apr 01; 13(2):87-99. PubMed ID: 8463453
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Evaluation of cognitive skills in ethanol- and cocaine- dependent patients during detoxification using P300 evoked response potentials (ERPs).
    Amass L, Lukas SE, Weiss RD, Mendelson J.
    NIDA Res Monogr; 1989 Apr 01; 95():353-4. PubMed ID: 2640992
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Why publish three negative articles on carbamazepine as a medication for the treatment of cocaine dependence?
    Johanson CE.
    Drug Alcohol Depend; 1995 Jun 01; 38(3):201-2. PubMed ID: 7555619
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV.
    Cottler LB, Shillington AM, Compton WM, Mager D, Spitznagel EL.
    Drug Alcohol Depend; 1993 Sep 01; 33(2):97-104. PubMed ID: 8261885
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.